Atlas Trials

Bexarotene and Fenretinide as Addition to Antipsychotic Treatment in Schizophrenia Patients

Clinical trial NCT00534898 · WITHDRAWN

Trial details

NCT number
NCT00534898
Sponsor
Beersheva Mental Health Center
Status
WITHDRAWN
Phase
Phase 3
Study type
INTERVENTIONAL
SchizophreniaSchizoaffective DisorderCognition

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.